SUDARSHAN PHARMA INDUSTRIES
Back to Cashflow Statement
|
SUDARSHAN PHARMA INDUSTRIES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹0.37 Cr | ₹-12 Cr | ₹11 Cr | ₹-1.02 Cr | ₹-0.01 Cr |
What is the latest Net Cash Inflow / Outflow ratio of SUDARSHAN PHARMA INDUSTRIES ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹0.37 Cr |
| Mar2024 | ₹-12 Cr |
| Mar2023 | ₹11 Cr |
| Mar2022 | ₹-1.02 Cr |
| Mar2021 | ₹-0.01 Cr |
How is Net Cash Inflow / Outflow of SUDARSHAN PHARMA INDUSTRIES Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.37 Cr | Positive | |
| Mar2024 | ₹-12 Cr | Negative | |
| Mar2023 | ₹11 Cr | Positive | |
| Mar2022 | ₹-1.02 Cr | Negative | |
| Mar2021 | ₹-0.01 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of SUDARSHAN PHARMA INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUDARSHAN PHARMA INDUSTRIES | ₹1,012.9 Cr | 7.1% | -4.8% | 19.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹458,249.0 Cr | 1.8% | -1.6% | 16.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | -1.2% | 17.3% | 38.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,891.0 Cr | -2.3% | -2% | 33.6% | Stock Analytics | |
| CIPLA | ₹115,927.0 Cr | 0.2% | 1.7% | -8.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,702.0 Cr | 1.2% | 3.6% | -7% | Stock Analytics | |
SUDARSHAN PHARMA INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUDARSHAN PHARMA INDUSTRIES | 7.1% |
-4.8% |
19.4% |
| SENSEX | -0.5% |
1.3% |
-4% |
You may also like the below Video Courses